# 逐題詳解 [上一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/162/) 第 163 / 180 [下一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/164/) 全部36000題詳解已提供中英顯示、基本符號及結構檢查，且第1–36000題已全部完成第二對話數理與中英語義覆核；不再有顯示／符號檢查候選。 候選群共 36000 題；已發布 36000 題詳解，其中數理覆核 36000 題、顯示／符號檢查候選 0 題；其餘 0 題尚未在此發布。 - [第 32401 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0001/) · R0063-32401 · 已數理覆核 - [第 32402 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0002/) · R0063-32402 · 已數理覆核 - [第 32403 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0003/) · R0063-32403 · 已數理覆核 - [第 32404 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0004/) · R0063-32404 · 已數理覆核 - [第 32405 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0005/) · R0063-32405 · 已數理覆核 - [第 32406 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0006/) · R0063-32406 · 已數理覆核 - [第 32407 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0007/) · R0063-32407 · 已數理覆核 - [第 32408 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0008/) · R0063-32408 · 已數理覆核 - [第 32409 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0009/) · R0063-32409 · 已數理覆核 - [第 32410 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0010/) · R0063-32410 · 已數理覆核 - [第 32411 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0011/) · R0063-32411 · 已數理覆核 - [第 32412 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0012/) · R0063-32412 · 已數理覆核 - [第 32413 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0013/) · R0063-32413 · 已數理覆核 - [第 32414 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0014/) · R0063-32414 · 已數理覆核 - [第 32415 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0015/) · R0063-32415 · 已數理覆核 - [第 32416 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0016/) · R0063-32416 · 已數理覆核 - [第 32417 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0017/) · R0063-32417 · 已數理覆核 - [第 32418 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0018/) · R0063-32418 · 已數理覆核 - [第 32419 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0019/) · R0063-32419 · 已數理覆核 - [第 32420 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0020/) · R0063-32420 · 已數理覆核 - [第 32421 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0021/) · R0063-32421 · 已數理覆核 - [第 32422 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0022/) · R0063-32422 · 已數理覆核 - [第 32423 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0023/) · R0063-32423 · 已數理覆核 - [第 32424 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0024/) · R0063-32424 · 已數理覆核 - [第 32425 題：qf-geometry-object-role](https://ocme.evemisslab.com/zh-Hant/questions/q-20260917-geometry-object-role-0025/) · R0063-32425 · 已數理覆核 - [第 32426 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0051/) · R0063-32426 · 已數理覆核 - [第 32427 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0052/) · R0063-32427 · 已數理覆核 - [第 32428 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0053/) · R0063-32428 · 已數理覆核 - [第 32429 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0054/) · R0063-32429 · 已數理覆核 - [第 32430 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0055/) · R0063-32430 · 已數理覆核 - [第 32431 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0056/) · R0063-32431 · 已數理覆核 - [第 32432 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0057/) · R0063-32432 · 已數理覆核 - [第 32433 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0058/) · R0063-32433 · 已數理覆核 - [第 32434 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0059/) · R0063-32434 · 已數理覆核 - [第 32435 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0060/) · R0063-32435 · 已數理覆核 - [第 32436 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0061/) · R0063-32436 · 已數理覆核 - [第 32437 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0062/) · R0063-32437 · 已數理覆核 - [第 32438 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0063/) · R0063-32438 · 已數理覆核 - [第 32439 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0064/) · R0063-32439 · 已數理覆核 - [第 32440 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0065/) · R0063-32440 · 已數理覆核 - [第 32441 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0066/) · R0063-32441 · 已數理覆核 - [第 32442 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0067/) · R0063-32442 · 已數理覆核 - [第 32443 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0068/) · R0063-32443 · 已數理覆核 - [第 32444 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0069/) · R0063-32444 · 已數理覆核 - [第 32445 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0070/) · R0063-32445 · 已數理覆核 - [第 32446 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0071/) · R0063-32446 · 已數理覆核 - [第 32447 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0072/) · R0063-32447 · 已數理覆核 - [第 32448 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0073/) · R0063-32448 · 已數理覆核 - [第 32449 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0074/) · R0063-32449 · 已數理覆核 - [第 32450 題：指定目標的纖維基數](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0075/) · R0063-32450 · 已數理覆核 - [第 32451 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0026/) · R0063-32451 · 已數理覆核 - [第 32452 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0027/) · R0063-32452 · 已數理覆核 - [第 32453 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0028/) · R0063-32453 · 已數理覆核 - [第 32454 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0029/) · R0063-32454 · 已數理覆核 - [第 32455 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0030/) · R0063-32455 · 已數理覆核 - [第 32456 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0031/) · R0063-32456 · 已數理覆核 - [第 32457 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0032/) · R0063-32457 · 已數理覆核 - [第 32458 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0033/) · R0063-32458 · 已數理覆核 - [第 32459 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0034/) · R0063-32459 · 已數理覆核 - [第 32460 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0035/) · R0063-32460 · 已數理覆核 - [第 32461 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0036/) · R0063-32461 · 已數理覆核 - [第 32462 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0037/) · R0063-32462 · 已數理覆核 - [第 32463 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0038/) · R0063-32463 · 已數理覆核 - [第 32464 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0039/) · R0063-32464 · 已數理覆核 - [第 32465 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0040/) · R0063-32465 · 已數理覆核 - [第 32466 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0041/) · R0063-32466 · 已數理覆核 - [第 32467 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0042/) · R0063-32467 · 已數理覆核 - [第 32468 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0043/) · R0063-32468 · 已數理覆核 - [第 32469 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0044/) · R0063-32469 · 已數理覆核 - [第 32470 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0045/) · R0063-32470 · 已數理覆核 - [第 32471 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0046/) · R0063-32471 · 已數理覆核 - [第 32472 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0047/) · R0063-32472 · 已數理覆核 - [第 32473 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0048/) · R0063-32473 · 已數理覆核 - [第 32474 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0049/) · R0063-32474 · 已數理覆核 - [第 32475 題：字典序首個碰撞見證](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0050/) · R0063-32475 · 已數理覆核 - [第 32476 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0076/) · R0063-32476 · 已數理覆核 - [第 32477 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0077/) · R0063-32477 · 已數理覆核 - [第 32478 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0078/) · R0063-32478 · 已數理覆核 - [第 32479 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0079/) · R0063-32479 · 已數理覆核 - [第 32480 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0080/) · R0063-32480 · 已數理覆核 - [第 32481 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0081/) · R0063-32481 · 已數理覆核 - [第 32482 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0082/) · R0063-32482 · 已數理覆核 - [第 32483 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0083/) · R0063-32483 · 已數理覆核 - [第 32484 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0084/) · R0063-32484 · 已數理覆核 - [第 32485 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0085/) · R0063-32485 · 已數理覆核 - [第 32486 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0086/) · R0063-32486 · 已數理覆核 - [第 32487 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0087/) · R0063-32487 · 已數理覆核 - [第 32488 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0088/) · R0063-32488 · 已數理覆核 - [第 32489 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0089/) · R0063-32489 · 已數理覆核 - [第 32490 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0090/) · R0063-32490 · 已數理覆核 - [第 32491 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0091/) · R0063-32491 · 已數理覆核 - [第 32492 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0092/) · R0063-32492 · 已數理覆核 - [第 32493 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0093/) · R0063-32493 · 已數理覆核 - [第 32494 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0094/) · R0063-32494 · 已數理覆核 - [第 32495 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0095/) · R0063-32495 · 已數理覆核 - [第 32496 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0096/) · R0063-32496 · 已數理覆核 - [第 32497 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0097/) · R0063-32497 · 已數理覆核 - [第 32498 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0098/) · R0063-32498 · 已數理覆核 - [第 32499 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0099/) · R0063-32499 · 已數理覆核 - [第 32500 題：限制定義域後的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0100/) · R0063-32500 · 已數理覆核 - [第 32501 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0001/) · R0064-32501 · 已數理覆核 - [第 32502 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0002/) · R0064-32502 · 已數理覆核 - [第 32503 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0003/) · R0064-32503 · 已數理覆核 - [第 32504 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0004/) · R0064-32504 · 已數理覆核 - [第 32505 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0005/) · R0064-32505 · 已數理覆核 - [第 32506 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0006/) · R0064-32506 · 已數理覆核 - [第 32507 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0007/) · R0064-32507 · 已數理覆核 - [第 32508 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0008/) · R0064-32508 · 已數理覆核 - [第 32509 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0009/) · R0064-32509 · 已數理覆核 - [第 32510 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0010/) · R0064-32510 · 已數理覆核 - [第 32511 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0011/) · R0064-32511 · 已數理覆核 - [第 32512 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0012/) · R0064-32512 · 已數理覆核 - [第 32513 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0013/) · R0064-32513 · 已數理覆核 - [第 32514 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0014/) · R0064-32514 · 已數理覆核 - [第 32515 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0015/) · R0064-32515 · 已數理覆核 - [第 32516 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0016/) · R0064-32516 · 已數理覆核 - [第 32517 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0017/) · R0064-32517 · 已數理覆核 - [第 32518 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0018/) · R0064-32518 · 已數理覆核 - [第 32519 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0019/) · R0064-32519 · 已數理覆核 - [第 32520 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0020/) · R0064-32520 · 已數理覆核 - [第 32521 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0021/) · R0064-32521 · 已數理覆核 - [第 32522 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0022/) · R0064-32522 · 已數理覆核 - [第 32523 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0023/) · R0064-32523 · 已數理覆核 - [第 32524 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0024/) · R0064-32524 · 已數理覆核 - [第 32525 題：有限總函數的單射性](https://ocme.evemisslab.com/zh-Hant/questions/q-20261004-advance-20261005-r01-injective-0025/) · R0064-32525 · 已數理覆核 - [第 32526 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0001/) · R0064-32526 · 已數理覆核 - [第 32527 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0002/) · R0064-32527 · 已數理覆核 - [第 32528 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0003/) · R0064-32528 · 已數理覆核 - [第 32529 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0004/) · R0064-32529 · 已數理覆核 - [第 32530 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0005/) · R0064-32530 · 已數理覆核 - [第 32531 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0006/) · R0064-32531 · 已數理覆核 - [第 32532 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0007/) · R0064-32532 · 已數理覆核 - [第 32533 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0008/) · R0064-32533 · 已數理覆核 - [第 32534 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0009/) · R0064-32534 · 已數理覆核 - [第 32535 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0010/) · R0064-32535 · 已數理覆核 - [第 32536 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0011/) · R0064-32536 · 已數理覆核 - [第 32537 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0012/) · R0064-32537 · 已數理覆核 - [第 32538 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0013/) · R0064-32538 · 已數理覆核 - [第 32539 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0014/) · R0064-32539 · 已數理覆核 - [第 32540 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0015/) · R0064-32540 · 已數理覆核 - [第 32541 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0016/) · R0064-32541 · 已數理覆核 - [第 32542 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0017/) · R0064-32542 · 已數理覆核 - [第 32543 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0018/) · R0064-32543 · 已數理覆核 - [第 32544 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0019/) · R0064-32544 · 已數理覆核 - [第 32545 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0020/) · R0064-32545 · 已數理覆核 - [第 32546 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0021/) · R0064-32546 · 已數理覆核 - [第 32547 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0022/) · R0064-32547 · 已數理覆核 - [第 32548 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0023/) · R0064-32548 · 已數理覆核 - [第 32549 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0024/) · R0064-32549 · 已數理覆核 - [第 32550 題：qf-integer-membership](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-membership-0025/) · R0064-32550 · 已數理覆核 - [第 32551 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0001/) · R0064-32551 · 已數理覆核 - [第 32552 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0002/) · R0064-32552 · 已數理覆核 - [第 32553 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0003/) · R0064-32553 · 已數理覆核 - [第 32554 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0004/) · R0064-32554 · 已數理覆核 - [第 32555 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0005/) · R0064-32555 · 已數理覆核 - [第 32556 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0006/) · R0064-32556 · 已數理覆核 - [第 32557 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0007/) · R0064-32557 · 已數理覆核 - [第 32558 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0008/) · R0064-32558 · 已數理覆核 - [第 32559 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0009/) · R0064-32559 · 已數理覆核 - [第 32560 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0010/) · R0064-32560 · 已數理覆核 - [第 32561 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0011/) · R0064-32561 · 已數理覆核 - [第 32562 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0012/) · R0064-32562 · 已數理覆核 - [第 32563 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0013/) · R0064-32563 · 已數理覆核 - [第 32564 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0014/) · R0064-32564 · 已數理覆核 - [第 32565 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0015/) · R0064-32565 · 已數理覆核 - [第 32566 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0016/) · R0064-32566 · 已數理覆核 - [第 32567 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0017/) · R0064-32567 · 已數理覆核 - [第 32568 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0018/) · R0064-32568 · 已數理覆核 - [第 32569 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0019/) · R0064-32569 · 已數理覆核 - [第 32570 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0020/) · R0064-32570 · 已數理覆核 - [第 32571 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0021/) · R0064-32571 · 已數理覆核 - [第 32572 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0022/) · R0064-32572 · 已數理覆核 - [第 32573 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0023/) · R0064-32573 · 已數理覆核 - [第 32574 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0024/) · R0064-32574 · 已數理覆核 - [第 32575 題：qf-integer-opposite](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-opposite-0025/) · R0064-32575 · 已數理覆核 - [第 32576 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0001/) · R0064-32576 · 已數理覆核 - [第 32577 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0002/) · R0064-32577 · 已數理覆核 - [第 32578 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0003/) · R0064-32578 · 已數理覆核 - [第 32579 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0004/) · R0064-32579 · 已數理覆核 - [第 32580 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0005/) · R0064-32580 · 已數理覆核 - [第 32581 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0006/) · R0064-32581 · 已數理覆核 - [第 32582 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0007/) · R0064-32582 · 已數理覆核 - [第 32583 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0008/) · R0064-32583 · 已數理覆核 - [第 32584 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0009/) · R0064-32584 · 已數理覆核 - [第 32585 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0010/) · R0064-32585 · 已數理覆核 - [第 32586 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0011/) · R0064-32586 · 已數理覆核 - [第 32587 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0012/) · R0064-32587 · 已數理覆核 - [第 32588 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0013/) · R0064-32588 · 已數理覆核 - [第 32589 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0014/) · R0064-32589 · 已數理覆核 - [第 32590 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0015/) · R0064-32590 · 已數理覆核 - [第 32591 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0016/) · R0064-32591 · 已數理覆核 - [第 32592 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0017/) · R0064-32592 · 已數理覆核 - [第 32593 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0018/) · R0064-32593 · 已數理覆核 - [第 32594 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0019/) · R0064-32594 · 已數理覆核 - [第 32595 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0020/) · R0064-32595 · 已數理覆核 - [第 32596 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0021/) · R0064-32596 · 已數理覆核 - [第 32597 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0022/) · R0064-32597 · 已數理覆核 - [第 32598 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0023/) · R0064-32598 · 已數理覆核 - [第 32599 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0024/) · R0064-32599 · 已數理覆核 - [第 32600 題：qf-integer-sign-classification](https://ocme.evemisslab.com/zh-Hant/questions/q-20260919-integer-sign-classification-0025/) · R0064-32600 · 已數理覆核 原題庫保留原有候選與驗證標記；顯示與符號檢查不記作數學複審或獨立重算。 [完整出版目錄 JSON](https://ocme.evemisslab.com/data/question-derivations/publication.json) · [數理覆核索引 JSON](https://ocme.evemisslab.com/data/question-derivations/index.json)[上一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/162/) 第 163 / 180 [下一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/164/)